Aptorum Group Limited Class A Ordinary Shares (APM)

Price$0.90

Favorite Metrics

Price vs S&P 500 (26W)-55.40%

Price vs S&P 500 (4W)-27.50%

Market Capitalization$7.21M

All Metrics

Book Value / Share (Quarterly)$3.15

P/TBV (Annual)0.74x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.10

Price vs S&P 500 (YTD)-20.60%

Gross Margin (TTM)7.10%

Net Profit Margin (TTM)-1115.14%

EPS (TTM)$-0.35

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.35

EPS (Annual)$-0.78

ROI (Annual)-17.45%

Gross Margin (Annual)2.45%

Net Profit Margin (5Y Avg)-1143.89%

Cash / Share (Quarterly)$0.32

ROA (Last FY)-26.46%

EBITD / Share (TTM)$-0.29

ROE (5Y Avg)-36.63%

Operating Margin (TTM)-1298.41%

Cash Flow / Share (Annual)$-0.21

P/B Ratio0.32x

P/B Ratio (Quarterly)0.64x

Net Income / Employee (Annual)$-4

EV / Revenue (TTM)6.99x

Net Interest Coverage (TTM)-27.30x

ROA (TTM)-12.07%

EPS Incl Extra (Annual)$-0.78

Current Ratio (Annual)0.22x

Quick Ratio (Quarterly)0.54x

3-Month Avg Trading Volume0.06M

52-Week Price Return-3.21%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$3.77

P/S Ratio (Annual)16.72x

Asset Turnover (Annual)0.02x

52-Week High$4.47

Operating Margin (5Y Avg)-2091.41%

EPS Excl Extra (Annual)$-0.78

Tangible BV CAGR (5Y)7.03%

26-Week Price Return-46.66%

Quick Ratio (Annual)0.21x

13-Week Price Return-16.46%

Total Debt / Equity (Annual)0.16x

Current Ratio (Quarterly)0.56x

Enterprise Value$8.393

Asset Turnover (TTM)0.07x

Book Value / Share Growth (5Y)39.70%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)28.05x

Pretax Margin (Annual)-1006.30%

Cash / Share (Annual)$0.16

3-Month Return Std Dev103.83%

Gross Margin (5Y Avg)-9.07%

Net Income / Employee (TTM)$-2

ROE (Last FY)-20.19%

Net Interest Coverage (Annual)-14.59x

EPS Basic Excl Extra (Annual)$-0.78

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.15x

EPS Incl Extra (TTM)$-0.35

Receivables Turnover (Annual)3.96x

ROI (TTM)-8.10%

P/S Ratio (TTM)6.00x

Pretax Margin (5Y Avg)-1367.78%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$3.77

Forward P/E0.29x

Price vs S&P 500 (52W)-38.31%

Year-to-Date Return-16.46%

5-Day Price Return1.19%

EPS Normalized (Annual)$-0.78

ROA (5Y Avg)-37.09%

Net Profit Margin (Annual)-654.79%

Month-to-Date Return11.26%

Cash Flow / Share (TTM)$-2.89

EBITD / Share (Annual)$-0.69

Operating Margin (Annual)-2486.03%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-32.28%

LT Debt / Equity (Quarterly)0.14x

EPS Basic Excl Extra (TTM)$-0.35

P/TBV (Quarterly)0.74x

P/B Ratio (Annual)0.74x

Inventory Turnover (TTM)28.05x

Pretax Margin (TTM)-1282.26%

Book Value / Share (Annual)$3.77

Price vs S&P 500 (13W)-19.33%

Beta-0.05x

Revenue / Share (TTM)$0.00

ROE (TTM)-9.33%

52-Week Low$0.65

Analyst Recommendations

Jun 2023

Jul 2023

Aug 2023

Sep 2023

4.00

Industry Peers — Measuring & Controlling Devices(10)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
APMAptorum Group Limited Class A Ordinary Shares	6.00x	—	7.10%	-1298.41%	$0.90
TMOThermo Fisher Scientific, Inc.	4.40x	6.70%	41.09%	17.38%	$526.02
ROKRockwell Automation, Inc.	5.44x	5.68%	50.32%	12.21%	$413.70
TRMBTrimble Inc. Common Stock	4.37x	-0.40%	70.37%	19.11%	$69.50
ONTOOnto Innovation Inc.	14.38x	12.55%	54.19%	13.22%	$295.09
MIRMirion Technologies, Inc.	5.29x	8.64%	47.40%	4.94%	$19.57
MASS908 Devices Inc. Common Stock	4.76x	15.88%	50.58%	-70.14%	$7.30
QSIQuantum-Si Incorporated Class A Common Stock	95.04x	—	47.33%	-4765.97%	$1.01
OWLTOwlet, Inc.	1.55x	6.99%	50.64%	-7.81%	$5.82
GEOSGeospace Technologies Corporation Common Stock	1.28x	4.76%	15.57%	-29.61%	$9.82
BCHTBirchtech Corp.	2.34x	8.79%	40.09%	-23.76%	$1.51

About

Aptorum Group develops clinical-stage therapeutics targeting oncology and infectious diseases, with emphasis on orphan cancer indications where treatment options are limited. Its pipeline includes ALS-4, SACT-1, and RPIDD programs, supported by healthcare services operations.